TrademarkDir
BARREGEN ESOPHAGEAL CANCER RISK CLASSIFIER
LIVE

Serial Number

86910938

Owner

Interpace Diagnostics, LLC

Attorney

Jeanne Hamburg

First Use Date

Sep 13, 2016

Filing Date

Feb 17, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

BARREGEN ESOPHAGEAL CANCER RISK CLASSIFIER Trademark

Serial Number: 86910938 • Registration: 5210362

BARREGEN ESOPHAGEAL CANCER RISK CLASSIFIER is a trademark filed by Interpace Diagnostics, LLC on February 17, 2016. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Interpace Diagnostics, LLC (3 trademarks)

Waterview Plaza, Suite 310
Parsippany, NJ 07054

Entity Type: 16

Trademark Details

Filing Date

February 17, 2016

Registration Date

May 23, 2017

First Use Anywhere

September 13, 2016

First Use in Commerce

September 13, 2016

Published for Opposition

July 19, 2016

Goods & Services

Medical diagnostic molecular testing, monitoring and reporting services to aid in the diagnosis and mitigation of esophageal cancer

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 23, 2026 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 8, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 8, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 8, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 8, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 8, 2023 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 3, 2022 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 3, 2022 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 3, 2022 APRE
TEAS SECTION 8 & 15 RECEIVED
May 23, 2022 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 23, 2022 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 6, 2020 TCCA
REGISTERED-PRINCIPAL REGISTER
May 23, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 20, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 19, 2017 CNPR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 2, 2017 GNRN
NON-FINAL ACTION E-MAILED
Feb 2, 2017 GNRT
SU - NON-FINAL ACTION - WRITTEN
Feb 2, 2017 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jan 10, 2017 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 29, 2016 AITU
USE AMENDMENT FILED
Dec 6, 2016 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 6, 2016 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 6, 2016 TCCA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 13, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 19, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jul 19, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 29, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 14, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 14, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 14, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 14, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 14, 2016 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 14, 2016 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 14, 2016 CNSA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jun 14, 2016 GPRN
PRIORITY ACTION E-MAILED
Jun 14, 2016 GPRA
PRIORITY ACTION WRITTEN
Jun 14, 2016 CPRA
ASSIGNED TO EXAMINER
Jun 2, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 25, 2016 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2016 NWOS
NEW APPLICATION ENTERED
Feb 20, 2016 NWAP

Related Trademarks

More from this Owner

EXPERIENCE THE INTERPACE DIFFERENCE

EXPERIENCE THE INTERPACE DIFFERENCE

BARREGEN ESOPHAGEAL CANCER RISK CLASSIFIER logo

BARREGEN ESOPHAGEAL CANCER RISK CLASSIFIER

BARREGEN

BARREGEN

BARREGEN

BARREGEN

BARREGEN

BARREGEN

BARREGEN

BARREGEN